Scott Sonnier in New Orleans, Louisiana

Home Louisiana New Orleans

Scott Sonnier has Hematology/oncology as his primary medical specialty. Their primary office is: 3434 Prytania St in New Orleans, Louisiana. There is an additional office location, for a total of two, for Scott Sonnier that can be viewed further down.

They're a part of the: Crescent City Physicians Inc medical group which has around 138 members. You can call their office at 504-325-2900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Louisiana State University School Of Medicine In New Orleans and graduated in 1995 (around 29 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Scott A Sonnier Office Phone and Directions

Scott Sonnier
Crescent City Physicians Inc
3434 Prytania St
New Orleans, Louisiana 70115
504-325-2900

Patient Ratings
Please rate your experience with Scott Sonnier below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 504-325-2900

Enter a starting address:

Healthcare Info for Scott Sonnier

Medical School: Louisiana State University School Of Medicine In New Orleans
Graduation Year: 1995
The Primary Medical Specialty for Scott Sonnier is listed as: Hematology/oncology
Approximate Years of Experience: 29
PAC (PECOS ID)#: 5799763835
NPI #: 1083679468
NPI Created On: 04/19/2006
NPI Last Updated Listed as: 03/08/2019
Primary Taxonomy Code: 207RH0003X
License Number:
14149R
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Vantage Health Plan, Inc.
Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: ENGLISH, English.

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787679525

Being Disputed:: No

Product Related: No

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787679563

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787679535

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787679545

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787679553

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787679569

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787679579

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787679589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787679599

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781015275

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Additional Office Locations

1. East Jefferson Physicians Group Llc
4204 Houma Blvd
Metairie, LA 70006
Fl 2
Group Members: 176

Phone: 504-325-2900

Enter a starting address:

Hematology/oncology Professionals in New Orleans

1.
Salvador Caputto

1401 Foucher St
New-orleans, LA
Crescent City Physicians Inc

2.
Salvador Caputto

100 W Harrison Ave
New-orleans, LA
Crescent City Physicians Inc

3.
Cori Morrison

200 Henry Clay Ave
New-orleans, LA
Louisiana State University School Of Med In New Orleans Faculty Grou

4.
Stefan Grant

150 S Liberty St
New-orleans, LA
Administrators Of The Tulane Educational Fund

5.
Caitlin Lopes

1514 Jefferson Hwy
New-orleans, LA
Ochsner Clinic Llc

6.
Michelle Loch

2000 Canal St
New-orleans, LA
Louisiana State University School Of Medicine In New Orleans Faculty G

Providers in Crescent City Physicians Inc

1.Terri Adams

3525 Prytania St
New Orleans La 70115-8127
Crescent City Physicians Inc
Nurse Practitioner

2.Michael Adinolfi

1401 Foucher St
New Orleans La 70115-3515
Crescent City Physicians Inc
General Surgery

3.Michael Adinolfi

3525 Prytania St
New Orleans La 70115-8100
Crescent City Physicians Inc
General Surgery

4.Michael Adinolfi

2820 Canal St
New Orleans La 70119-6302
Crescent City Physicians Inc
General Surgery

5.Shradha Ahuja

2121 Ridgelake Dr
Metairie La 70001-2080
Crescent City Physicians Inc
Hematology/oncology

6.Shanti Akasapu

3700 Saint Charles Ave
New Orleans La 70115-4637
Crescent City Physicians Inc
Internal Medicine

View all 138 members of Crescent City Physicians Inc medical group